Day: August 1, 2023
-
Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology
Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD…
Read More » -
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical…
Read More » -
Heads of the Rome-based UN food and agriculture agencies call for greater investments in South Sudan to avoid a catastrophic food crisis
The cost of inaction in addressing South Sudan’s complex food, climate, and insecurity crises will be felt in the loss…
Read More » -
‘Breastfeeding is a lifeline’: Women in DRC, South Sudan and Syria talk nutrition
It’s precisely in emergency contexts, where it is most crucial, that breastfeeding can be most challenging,” says Cindy McCain, Executive…
Read More » -
WEATHER: PARTLY CLOUDY, SLIGHT TEMPERATURE DECREASE
Wednesday's weather is expected to be partly cloudy with a slight drop in temperature degrees, according to the Beirut airport-based…
Read More » -
INTERMITTENT CLASHES DESPITE CEASEFIRE IN AIN-EL-HILWE
Fierce clashes have continued throughout the night in the Palestinian refugee camp of Ain-el-Hilwe in Saida despite an agreed ceasefire,…
Read More »